GL1X · GenesisL1 explorer

UniProt A0A444M080

CRISPR type I-F/YPEST-associated protein Csy3 (A0A444M080)

CRISPR type I-F/YPEST-associated protein Csy3 (UniProt A0A444M080): 13 experimental structures on GenesisL1, 34 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
A0A444M080
Protein
CRISPR type I-F/YPEST-associated protein Csy3
Experimental structures
13
Predicted models
0
Pockets
34 · 2 records with a druggable one

Structures

13 records of A0A444M080 in the MolNFT archive: 13 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
6VQVType I-F CRISPR-csy complex with its inhibitor ACRF9electron microscopyE, F, G, H, I, J——
6VQWType I-F CRISPR-csy complex with its inhibitor ACRF8electron microscopyD, E, F, G, H, I——
6VQXType I-F CRISPR-csy complex with its inhibitor ACRF6electron microscopyD, E, F, G, H, I——
6W1XCryo-EM structure of anti-CRISPR ACRIF9, bound to the type I-F crrna- guided CRISPR surveillance…electron microscopyC, D, E, F, G, H——
6WHICryo-electron microscopy structure of the type I-F CRISPR RNA-guided surveillance complex bound to…electron microscopyC, D, E, F, G, H——
7JZWCryo-EM structure of CRISPR-Cas surveillance complex with AcrIF4electron microscopyE, D, F, G, H, I——
7JZWCryo-EM structure of CRISPR-CAS surveillance complex with ACRIF4electron microscopyE, D, F, G, H, I——
7JZXCryo-EM structure of CRISPR-CAS surveillance complex with ACRIF7electron microscopyE, D, F, G, H, I——
7JZYCryoEM structure of a CRISPR-Cas complexelectron microscopyD, E, F, G, H, I——
7JZYCryoem structure of a CRISPR-CAS complexelectron microscopyD, E, F, G, H, I——
7JZZCryo-EM structure of CRISPR-CAS surveillance complex with ACRIF14electron microscopyD, E, F, G, H, I——
7T3JCryo-EM structure of Csy-AcrIF24electron microscopyD, E, F, G, H, I—18 (best 0.86)
7T3KCryo-EM structure of Csy-AcrIF24 dimerelectron microscopyD, E, F, G, H, I, d, e, f, g, h, i—16 (best 0.86)

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.